Conjugate Vaccine Market Revenue 2024 to 2034
Conjugate Vaccine Market Revenue 2024 to 2034
The Conjugate Vaccine Market is forecast to rise from USD 11.30 Bn in 2024 to USD 46.11 Bn by 2034 at 15.10% CAGR, supported by global immunization programs and rising investments in vaccine R&D.
Report ID: 10408
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 11.30 Bn
Forecast Year,
USD 46.11 Bn
CAGR, 2025 -
15.10%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Conjugate Vaccine Market Size Analysis
Conjugate Vaccine Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 3.62 | 4.17 | 4.82 | 5.52 | 6.38 | 7.34 | 8.41 | 9.72 | 11.26 | 12.96 | 14.94 |
| Biologics | 3.84 | 4.39 | 5.03 | 5.81 | 6.68 | 7.69 | 8.93 | 10.23 | 11.72 | 13.45 | 15.46 |
| Advanced Therapies | 2.03 | 2.37 | 2.72 | 3.14 | 3.62 | 4.17 | 4.77 | 5.49 | 6.29 | 7.28 | 8.38 |
| Others | 1.81 | 2.08 | 2.41 | 2.76 | 3.16 | 3.63 | 4.17 | 4.80 | 5.54 | 6.38 | 7.33 |
Conjugate Vaccine Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 4.07 | 4.68 | 5.39 | 6.18 | 7.09 | 8.14 | 9.34 | 10.70 | 12.29 | 14.13 | 16.24 |
| Cardio-Metabolic | 2.03 | 2.35 | 2.72 | 3.12 | 3.62 | 4.16 | 4.80 | 5.54 | 6.41 | 7.37 | 8.49 |
| Infectious | 1.81 | 2.07 | 2.40 | 2.77 | 3.19 | 3.66 | 4.25 | 4.90 | 5.63 | 6.49 | 7.51 |
| CNS | 1.58 | 1.82 | 2.08 | 2.40 | 2.77 | 3.18 | 3.65 | 4.21 | 4.87 | 5.62 | 6.42 |
| Others | 1.81 | 2.09 | 2.39 | 2.76 | 3.17 | 3.69 | 4.24 | 4.89 | 5.62 | 6.47 | 7.45 |
Conjugate Vaccine Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 4.97 | 5.71 | 6.56 | 7.55 | 8.70 | 10.03 | 11.58 | 13.29 | 15.29 | 17.56 | 20.22 |
| Retail Pharmacy | 4.07 | 4.68 | 5.39 | 6.21 | 7.14 | 8.19 | 9.37 | 10.80 | 12.41 | 14.32 | 16.48 |
| Online/Other | 2.26 | 2.62 | 3.02 | 3.47 | 4.00 | 4.61 | 5.33 | 6.15 | 7.11 | 8.19 | 9.42 |
Conjugate Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 4.52 | 5.23 | 6.04 | 6.95 | 8.01 | 9.23 | 10.62 | 12.25 | 14.10 | 16.11 | 18.48 |
| Europe | 3.17 | 3.63 | 4.16 | 4.81 | 5.51 | 6.35 | 7.32 | 8.40 | 9.68 | 11.22 | 12.90 |
| Asia Pacific | 2.71 | 3.11 | 3.57 | 4.10 | 4.74 | 5.43 | 6.25 | 7.20 | 8.26 | 9.52 | 11.03 |
| Latin America | 0.45 | 0.52 | 0.60 | 0.69 | 0.79 | 0.91 | 1.05 | 1.21 | 1.39 | 1.61 | 1.84 |
| Middle East & Africa | 0.45 | 0.52 | 0.60 | 0.68 | 0.79 | 0.90 | 1.04 | 1.20 | 1.38 | 1.60 | 1.86 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
